News & Events
April 26, 2017John Tucker Appointed as Chief Executive Officer of scPharmaceuticals
FOR IMMEDIATE RELEASE: LEXINGTON, MA., —scPharmaceuticals, Inc., a privately held biopharmaceutical company transforming patient care and healthcare costs through innovative subcutaneous drug delivery, today announced the appointment of John Tucker as president and chief executive officer, effective immediately.
January 24, 2017scPharmaceuticals Announces Start of SUBQ-HF NHLBI Study with Its Subcutaneous Furosemide Product
FOR IMMEDIATE RELEASE: LEXINGTON, MA., —scPharmaceuticals, Inc., a privately held biopharmaceutical company developing transformative pharmaceutical products for subcutaneous delivery, announced today the start of the first phase of a study conducted by the Heart Failure Clinical Research Network (HFN).